Does Eliquis Cause Blood in Urine?
Yes, Eliquis (apixaban), an anticoagulant that prevents blood clots, can cause blood in urine, known as hematuria. This occurs because the drug inhibits clotting factors, increasing bleeding risk anywhere in the body, including the urinary tract. Clinical trials reported hematuria in 1.7% of patients on Eliquis versus 0.9% on warfarin, with rates up to 3-4% in some post-marketing data.[1][2]
How Common Is This Side Effect?
Hematuria appears in 2-6% of Eliquis users across studies, more frequent with higher doses or concurrent antiplatelet use like aspirin. It's often microscopic (not visible) but can become gross hematuria (visible red urine). Risk rises with age over 75, kidney impairment, or invasive procedures.[1][3]
What Should You Do If You Notice Blood in Urine?
Stop ignoring it—contact your doctor immediately. They may check for underlying causes like urinary tract infections, kidney stones, or cancer, then adjust Eliquis dose, switch drugs, or pause treatment. Severe cases need urgent care to rule out life-threatening bleeds.[2][4]
Why Does Eliquis Increase Bleeding Risk More in Urine?
Eliquis blocks factor Xa, thinning blood systemically. The urinary tract's high vascularity and frequent minor trauma (e.g., from dehydration or exercise) amplify this. Unlike warfarin, Eliquis has no routine antidote monitoring, but reversal agents like andexanet alfa exist for emergencies.[1][3]
Compared to Other Blood Thinners
| Drug | Hematuria Rate | Notes |
|------|---------------|-------|
| Eliquis (apixaban) | 2-6% | Lower overall bleed risk than warfarin; similar to Xarelto. [1] |
| Xarelto (rivaroxaban) | 3-5% | Slightly higher urinary bleeds in head-to-head trials. [3] |
| Pradaxa (dabigatran) | 2-4% | More gastrointestinal bleeds, less urinary. [3] |
| Warfarin | 1-3% | Requires INR monitoring; vitamin K reversal easier. [2] |
Eliquis edges out warfarin for fewer major bleeds overall, per ARISTOTLE trial data.[1]
Who Is at Higher Risk?
- Elderly patients (over 75)
- Those with creatinine clearance under 50 mL/min
- Users of NSAIDs, SSRIs, or dual antiplatelets
- History of ulcers or prior bleeds
Prescribers weigh clot risk (e.g., atrial fibrillation) against these factors.[4]
When Does the Manufacturer's Patent Expire?
Eliquis patents expire in 2026-2028 in the US, opening doors to generics that could lower costs and bleeding monitoring needs. Check DrugPatentWatch.com for exact dates and challenges.[5]
Sources
[1] FDA Eliquis Label
[2] NEJM ARISTOTLE Trial
[3] PubMed Review on DOACs and Hematuria
[4] American Heart Association Guidelines
[5] DrugPatentWatch.com - Eliquis Patents